The Extracellular Matrix: An Overview 2010
DOI: 10.1007/978-3-642-16555-9_11
|View full text |Cite
|
Sign up to set email alerts
|

Matricellular Proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
3

Relationship

5
2

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 288 publications
0
12
0
Order By: Relevance
“…TSP1/CD47 signaling plays important roles in tumor and wound angiogenesis, fixed ischemic injuries, and ischemia/reperfusion injuries, and readers are referred to recent reviews (Frazier et al, 2010; Isenberg et al, 2008a; Isenberg et al, 2009b; Roberts and Lau, 2011). Elevated plasma TSP1 levels correlate positively with cardiovascular disease (Smadja et al, 2011), suggesting that TSP1 is a biomarker for and potentiator of vascular dysfunction.…”
Section: Pathophysiological Functions and Therapeutic Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…TSP1/CD47 signaling plays important roles in tumor and wound angiogenesis, fixed ischemic injuries, and ischemia/reperfusion injuries, and readers are referred to recent reviews (Frazier et al, 2010; Isenberg et al, 2008a; Isenberg et al, 2009b; Roberts and Lau, 2011). Elevated plasma TSP1 levels correlate positively with cardiovascular disease (Smadja et al, 2011), suggesting that TSP1 is a biomarker for and potentiator of vascular dysfunction.…”
Section: Pathophysiological Functions and Therapeutic Applicationsmentioning
confidence: 99%
“…Thrombospondin-1 (TSP1) is a matricellular protein that is transiently expressed in extracellular matrix and modulates cell function in a context-specific manner by engaging cell surface receptors and other components of the extracellular matrix (Bornstein, 1995; Roberts and Lau, 2011). TSP1 circulates at ~100 pM levels in plasma, and platelet α-granules represent a major preformed storage pool that can rapidly increase extracellular concentrations of the protein at sites of injury.…”
Section: Introductionmentioning
confidence: 99%
“…Matricellular proteins are not constitutive structural elements of extracellular matrix, rather they function as regulatory molecules that are present in extracellular matrix at specific times during development, tissue remodeling, and responses to injury or chronic disease states. Thrombospondin-1 (TSP1) is a prototypical member of this family, which has grown to include four additional thrombospondins (TSPs), tenascins, periostin, the secreted protein acidic and rich in cysteine (SPARC) family, the five small integrin-binding ligand N-linked glycoprotein (SIB-LING) family members, the CCN (CYR61, CTGF [connective tissue growth factor], and NOV [nephroblastoma overexpressed gene]) family, and other thrombospondinrepeat (TSR)-containing proteins such as the a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family (142,169,209) (Fig. 1).…”
mentioning
confidence: 99%
“…These proteins characteristically contain binding sites for some major structural elements in the matrix, binding sites for specific cell surface receptors, and in some cases domains that enzymatic alter other matrix components and that sequester or modulate the activities of specific growth factors. Such proteins have been classified as matricellular proteins [7,8]. The prototypical matricellular proteins were thrombospondin-1, tenascin-C, and secreted protein acidic and rich in cysteine (SPARC).…”
mentioning
confidence: 99%
“…The CCN family of cysteine-rich matricellular proteins contains 6 members in vertebrates [8,24]. These multidomain proteins are related to thrombospondins in that they contain a thrombospondin type 1 repeat.…”
mentioning
confidence: 99%